Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Corsini

Showing results (51-60 of 200) with videos related to

Pageof 20
Sort By:
Journal of Clinical Medicine|February 24, 2024
Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative ReviewNicola Ferri, Massimiliano Ruscica, Sergio Fazio, et al.
Expert Opinion on Drug Safety|February 20, 2020
Treatment of dyslipidemia in kidney transplantationClaudio Ponticelli, Lorenzo Arnaboldi, Gabriella Moroni, et al.
Drugs|June 18, 2004
Fluvastatin: clinical and safety profileAlberto Corsini, Terry A Jacobson, Christie M Ballantyne
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9Lorenzo Arnaboldi, Zixiong Tang, Nicola Ferri, et al.
Pharmacological Research|April 20, 2006
Hypolipidemic therapy for the metabolic syndromeAndrea Cignarella, Stefano Bellosta, Alberto Corsini, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 26, 2020
Lipoprotein(a) and PCSK9 inhibition: clinical evidenceMassimiliano Ruscica, Maria Francesca Greco, Nicola Ferri, et al.
Current Atherosclerosis Reports|September 15, 2023
Fixed Combination for the Treatment of DyslipidaemiaNicola Ferri, Massimiliano Ruscica, Raul D Santos, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 2, 2011
Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cellsNicola Ferri, Carolina Magdalen Greco, Giuseppe Maiocchi, et al.
Atherosclerosis|November 6, 2017
PCSK9 antagonists and inflammationMassimiliano Ruscica, Nicola Ferri, Alberto Corsini, et al.
Expert Opinion on Biological Therapy|January 7, 2017
Bococizumab for the treatment of hypercholesterolaemiaNicola Ferri, Alberto Corsini, Cesare R Sirtori, et al.
Pageof 20

Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
Journal of Clinical Medicine|February 24, 2024
Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative ReviewNicola Ferri, Massimiliano Ruscica, Sergio Fazio, et al.
Expert Opinion on Drug Safety|February 20, 2020
Treatment of dyslipidemia in kidney transplantationClaudio Ponticelli, Lorenzo Arnaboldi, Gabriella Moroni, et al.
Drugs|June 18, 2004
Fluvastatin: clinical and safety profileAlberto Corsini, Terry A Jacobson, Christie M Ballantyne
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9Lorenzo Arnaboldi, Zixiong Tang, Nicola Ferri, et al.
Pharmacological Research|April 20, 2006
Hypolipidemic therapy for the metabolic syndromeAndrea Cignarella, Stefano Bellosta, Alberto Corsini, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 26, 2020
Lipoprotein(a) and PCSK9 inhibition: clinical evidenceMassimiliano Ruscica, Maria Francesca Greco, Nicola Ferri, et al.
Current Atherosclerosis Reports|September 15, 2023
Fixed Combination for the Treatment of DyslipidaemiaNicola Ferri, Massimiliano Ruscica, Raul D Santos, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 2, 2011
Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cellsNicola Ferri, Carolina Magdalen Greco, Giuseppe Maiocchi, et al.
Atherosclerosis|November 6, 2017
PCSK9 antagonists and inflammationMassimiliano Ruscica, Nicola Ferri, Alberto Corsini, et al.
Expert Opinion on Biological Therapy|January 7, 2017
Bococizumab for the treatment of hypercholesterolaemiaNicola Ferri, Alberto Corsini, Cesare R Sirtori, et al.
Pageof 20